<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://ascptpod.com/wp-content/plugins/seriously-simple-podcasting/templates/feed-stylesheet.xsl"?><rss version="2.0"
	 xmlns:content="http://purl.org/rss/1.0/modules/content/"
	 xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	 xmlns:dc="http://purl.org/dc/elements/1.1/"
	 xmlns:atom="http://www.w3.org/2005/Atom"
	 xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	 xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	 xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd"
	 xmlns:googleplay="http://www.google.com/schemas/play-podcasts/1.0"
	 xmlns:podcast="https://podcastindex.org/namespace/1.0"
	>
		<channel>
		<title>ASCPTPod</title>
		<atom:link href="https://ascptpod.com/feed/podcast/ascptpod/" rel="self" type="application/rss+xml"/>
		<link>https://ascptpod.com/series/ascptpod/</link>
		<description>The official podcast stream of the American Society for Clinical Pharmacology &amp; Therapeutics (ASCPT).</description>
		<lastBuildDate>Fri, 06 Mar 2026 12:00:13 +0000</lastBuildDate>
		<language>en-US</language>
		<copyright>© 2023 ASCPT Podcast Channel</copyright>
		<itunes:subtitle>The official podcast stream of the American Society for Clinical Pharmacology &amp; Therapeutics (ASCPT).</itunes:subtitle>
		<itunes:author>ASCPT Podcast Channel</itunes:author>
		<itunes:type>episodic</itunes:type>
		<itunes:summary>The official podcast stream of the American Society for Clinical Pharmacology &amp; Therapeutics (ASCPT).</itunes:summary>
		<itunes:owner>
			<itunes:name>ASCPT Podcast Channel</itunes:name>
			<itunes:email>contact@makeworthymedia.com</itunes:email>
		</itunes:owner>
		<itunes:explicit>false</itunes:explicit>
		<itunes:image href="https://ascptpod.com/wp-content/uploads/2020/03/ascpt-podcast-network-cover-01.png"></itunes:image>
			<image>
				<url>https://ascptpod.com/wp-content/uploads/2020/03/ascpt-podcast-network-cover-01.png</url>
				<title>ASCPTPod</title>
				<link>https://ascptpod.com/series/ascptpod/</link>
			</image>
		<itunes:category text="Science">
			<itunes:category text="Medicine"></itunes:category>
		</itunes:category>
		<googleplay:author><![CDATA[ASCPT Podcast Channel]]></googleplay:author>
			<googleplay:email>contact@makeworthymedia.com</googleplay:email>			<googleplay:description>The official podcast stream of the American Society for Clinical Pharmacology &amp; Therapeutics (ASCPT).</googleplay:description>
			<googleplay:explicit>No</googleplay:explicit>
			<googleplay:image href="https://ascptpod.com/wp-content/uploads/2020/03/ascpt-podcast-network-cover-01.png"></googleplay:image>
			<podcast:locked owner="contact@makeworthymedia.com">yes</podcast:locked>
		<podcast:guid>3bdc2b61-5e55-51eb-8ada-7a3509c3e3c2</podcast:guid>
		
		<!-- podcast_generator="SSP by Castos/3.14.3" Seriously Simple Podcasting plugin for WordPress (https://wordpress.org/plugins/seriously-simple-podcasting/) -->
		<generator>https://wordpress.org/?v=6.9.4</generator>

<item>
	<title>PSP Call for Papers: Model-Based Innovations in Pediatric Rare Disease</title>
	<link>https://ascptpod.com/podcast/psp-call-for-papers-model-based-innovations-in-pediatric-rare-disease/</link>
	<pubDate>Mon, 18 Nov 2024 19:43:17 +0000</pubDate>
	<dc:creator><![CDATA[ASCPT Podcast Channel]]></dc:creator>
	<guid isPermaLink="false">https://ascptpod.com/?post_type=podcast&#038;p=353</guid>
	<description><![CDATA[Join PSP Associate Editors Ping Zhao and Rajat Desikan as well as former Editor-in-Training Jane Knöchel as they discuss the journal&#8217;s latest Call for Papers &#8220;Model-Based Innovations in Pediatric Rare Disease.&#8221; Find out why the PSP Editorial Team chose to highlight this topic in 2025, what types of submissions they&#8217;re hoping to receive, why publishing [&#8230;]]]></description>
	<itunes:subtitle><![CDATA[Join PSP Associate Editors Ping Zhao and Rajat Desikan as well as former Editor-in-Training Jane Knöchel as they discuss the journal&#8217;s latest Call for Papers &#8220;Model-Based Innovations in Pediatric Rare Disease.&#8221; Find out why the PSP Edit]]></itunes:subtitle>
	<content:encoded><![CDATA[Join PSP Associate Editors Ping Zhao and Rajat Desikan as well as former Editor-in-Training Jane Knöchel as they discuss the journal&#8217;s latest Call for Papers &#8220;Model-Based Innovations in Pediatric Rare Disease.&#8221; Find out why the PSP Editorial Team chose to highlight this topic in 2025, what types of submissions they&#8217;re hoping to receive, why publishing [&#8230;]]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/353/psp-call-for-papers-model-based-innovations-in-pediatric-rare-disease.mp3" length="7111990" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Join PSP Associate Editors Ping Zhao and Rajat Desikan as well as former Editor-in-Training Jane Knöchel as they discuss the journal&#8217;s latest Call for Papers &#8220;Model-Based Innovations in Pediatric Rare Disease.&#8221; Find out why the PSP Editorial Team chose to highlight this topic in 2025, what types of submissions they&#8217;re hoping to receive, why publishing [&#8230;]]]></itunes:summary>
	<itunes:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></itunes:image>
	<image>
		<url>https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png</url>
		<title>PSP Call for Papers: Model-Based Innovations in Pediatric Rare Disease</title>
	</image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>8:53</itunes:duration>
	<itunes:author><![CDATA[ASCPT Podcast Channel]]></itunes:author>	<googleplay:description><![CDATA[Join PSP Associate Editors Ping Zhao and Rajat Desikan as well as former Editor-in-Training Jane Knöchel as they discuss the journal&#8217;s latest Call for Papers &#8220;Model-Based Innovations in Pediatric Rare Disease.&#8221; Find out why the PSP Editorial Team chose to highlight this topic in 2025, what types of submissions they&#8217;re hoping to receive, why publishing [&#8230;]]]></googleplay:description>
	<googleplay:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Bench-to-Budget: CPT Seeks Pharmacoepidemiology-Themed Research</title>
	<link>https://ascptpod.com/podcast/bench-to-budget-cpt-seeks-pharmacoepidemiology-themed-research/</link>
	<pubDate>Wed, 31 Jul 2024 19:45:51 +0000</pubDate>
	<dc:creator><![CDATA[ASCPT Podcast Channel]]></dc:creator>
	<guid isPermaLink="false">https://ascptpod.com/?post_type=podcast&#038;p=345</guid>
	<description><![CDATA[Clinical Pharmacology &#38; Therapeutics (CPT) has launched a Call for Papers for its April 2025 themed issue centering on pharmacoepidemiology, titled &#8220;Bench to Budget: Streamlining the Full Spectrum of Evidence Integration to Enhance Efficiency and Impact of Drug-Development and Patient Access.&#8221; Join host Alaina Webster as she welcomes CPT Editor-in-Chief Dr. Piet van der Graaf, Associate Editor Dr. [&#8230;]]]></description>
	<itunes:subtitle><![CDATA[Clinical Pharmacology &#38; Therapeutics (CPT) has launched a Call for Papers for its April 2025 themed issue centering on pharmacoepidemiology, titled &#8220;Bench to Budget: Streamlining the Full Spectrum of Evidence Integration to Enhance Efficiency a]]></itunes:subtitle>
	<content:encoded><![CDATA[Clinical Pharmacology &#38; Therapeutics (CPT) has launched a Call for Papers for its April 2025 themed issue centering on pharmacoepidemiology, titled &#8220;Bench to Budget: Streamlining the Full Spectrum of Evidence Integration to Enhance Efficiency and Impact of Drug-Development and Patient Access.&#8221; Join host Alaina Webster as she welcomes CPT Editor-in-Chief Dr. Piet van der Graaf, Associate Editor Dr. [&#8230;]]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/345/bench-to-budget-cpt-seeks-pharmacoepidemiology-themed-research.mp3" length="10662430" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Clinical Pharmacology &#38; Therapeutics (CPT) has launched a Call for Papers for its April 2025 themed issue centering on pharmacoepidemiology, titled &#8220;Bench to Budget: Streamlining the Full Spectrum of Evidence Integration to Enhance Efficiency and Impact of Drug-Development and Patient Access.&#8221; Join host Alaina Webster as she welcomes CPT Editor-in-Chief Dr. Piet van der Graaf, Associate Editor Dr. [&#8230;]]]></itunes:summary>
	<itunes:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></itunes:image>
	<image>
		<url>https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png</url>
		<title>Bench-to-Budget: CPT Seeks Pharmacoepidemiology-Themed Research</title>
	</image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>13:41</itunes:duration>
	<itunes:author><![CDATA[ASCPT Podcast Channel]]></itunes:author>	<googleplay:description><![CDATA[Clinical Pharmacology &#38; Therapeutics (CPT) has launched a Call for Papers for its April 2025 themed issue centering on pharmacoepidemiology, titled &#8220;Bench to Budget: Streamlining the Full Spectrum of Evidence Integration to Enhance Efficiency and Impact of Drug-Development and Patient Access.&#8221; Join host Alaina Webster as she welcomes CPT Editor-in-Chief Dr. Piet van der Graaf, Associate Editor Dr. [&#8230;]]]></googleplay:description>
	<googleplay:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Call for Papers: DEI in Clinical and Translational Science</title>
	<link>https://ascptpod.com/podcast/call-for-papers-dei-in-clinical-and-translational-science/</link>
	<pubDate>Wed, 17 Jul 2024 16:22:35 +0000</pubDate>
	<dc:creator><![CDATA[ASCPT Podcast Channel]]></dc:creator>
	<guid isPermaLink="false">https://ascptpod.com/?post_type=podcast&#038;p=339</guid>
	<description><![CDATA[Clinical and Translational Science (CTS) has launched a Call for Papers for its third special collection, which will focus on diversity, equity, and inclusion (DEI) as it applies to clinical pharmacology and translational science. Join host Alaina Webster as she welcomes CTS Associate Editor Dr. Elvin Price to discuss types of submissions the journal would most like to [&#8230;]]]></description>
	<itunes:subtitle><![CDATA[Clinical and Translational Science (CTS) has launched a Call for Papers for its third special collection, which will focus on diversity, equity, and inclusion (DEI) as it applies to clinical pharmacology and translational science. Join host Alaina Webste]]></itunes:subtitle>
	<content:encoded><![CDATA[Clinical and Translational Science (CTS) has launched a Call for Papers for its third special collection, which will focus on diversity, equity, and inclusion (DEI) as it applies to clinical pharmacology and translational science. Join host Alaina Webster as she welcomes CTS Associate Editor Dr. Elvin Price to discuss types of submissions the journal would most like to [&#8230;]]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/339/call-for-papers-dei-in-clinical-and-translational-science.mp3" length="11473486" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Clinical and Translational Science (CTS) has launched a Call for Papers for its third special collection, which will focus on diversity, equity, and inclusion (DEI) as it applies to clinical pharmacology and translational science. Join host Alaina Webster as she welcomes CTS Associate Editor Dr. Elvin Price to discuss types of submissions the journal would most like to [&#8230;]]]></itunes:summary>
	<itunes:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></itunes:image>
	<image>
		<url>https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png</url>
		<title>Call for Papers: DEI in Clinical and Translational Science</title>
	</image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>15:36</itunes:duration>
	<itunes:author><![CDATA[ASCPT Podcast Channel]]></itunes:author>	<googleplay:description><![CDATA[Clinical and Translational Science (CTS) has launched a Call for Papers for its third special collection, which will focus on diversity, equity, and inclusion (DEI) as it applies to clinical pharmacology and translational science. Join host Alaina Webster as she welcomes CTS Associate Editor Dr. Elvin Price to discuss types of submissions the journal would most like to [&#8230;]]]></googleplay:description>
	<googleplay:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Check Out CTS’s Special Collection of Real-World Evidence/Real-World Data Research!</title>
	<link>https://ascptpod.com/podcast/check-out-ctss-special-collection-of-real-world-evidence-real-world-data-research/</link>
	<pubDate>Mon, 24 Jun 2024 22:31:52 +0000</pubDate>
	<dc:creator><![CDATA[ASCPT Podcast Channel]]></dc:creator>
	<guid isPermaLink="false">https://ascptpod.com/?post_type=podcast&#038;p=336</guid>
	<description><![CDATA[Clinical and Translational Science Associate Editor Paulien Ravenstijn joins host Alaina Webster to talk about the papers included in its first Special Collection. This exciting collection focuses on Real-World Evidence and Real-World Data, and is capped off by a great Editorial contribution from Paulien. Learn more about the thought process behind this collection and what [&#8230;]]]></description>
	<itunes:subtitle><![CDATA[Clinical and Translational Science Associate Editor Paulien Ravenstijn joins host Alaina Webster to talk about the papers included in its first Special Collection. This exciting collection focuses on Real-World Evidence and Real-World Data, and is capped]]></itunes:subtitle>
	<content:encoded><![CDATA[Clinical and Translational Science Associate Editor Paulien Ravenstijn joins host Alaina Webster to talk about the papers included in its first Special Collection. This exciting collection focuses on Real-World Evidence and Real-World Data, and is capped off by a great Editorial contribution from Paulien. Learn more about the thought process behind this collection and what [&#8230;]]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/336/check-out-ctss-special-collection-of-real-world-evidence-real-world-data-research.mp3" length="5766862" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Clinical and Translational Science Associate Editor Paulien Ravenstijn joins host Alaina Webster to talk about the papers included in its first Special Collection. This exciting collection focuses on Real-World Evidence and Real-World Data, and is capped off by a great Editorial contribution from Paulien. Learn more about the thought process behind this collection and what [&#8230;]]]></itunes:summary>
	<itunes:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></itunes:image>
	<image>
		<url>https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png</url>
		<title>Check Out CTS’s Special Collection of Real-World Evidence/Real-World Data Research!</title>
	</image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>7:28</itunes:duration>
	<itunes:author><![CDATA[ASCPT Podcast Channel]]></itunes:author>	<googleplay:description><![CDATA[Clinical and Translational Science Associate Editor Paulien Ravenstijn joins host Alaina Webster to talk about the papers included in its first Special Collection. This exciting collection focuses on Real-World Evidence and Real-World Data, and is capped off by a great Editorial contribution from Paulien. Learn more about the thought process behind this collection and what [&#8230;]]]></googleplay:description>
	<googleplay:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Submit Your Artificial Intelligence/Machine Learning Research to CTS!</title>
	<link>https://ascptpod.com/podcast/submit-your-artificial-intelligence-machine-learning-research-to-cts/</link>
	<pubDate>Wed, 12 Jun 2024 18:20:14 +0000</pubDate>
	<dc:creator><![CDATA[ASCPT Podcast Channel]]></dc:creator>
	<guid isPermaLink="false">https://ascptpod.com/?post_type=podcast&#038;p=331</guid>
	<description><![CDATA[Clinical and Translational Science (CTS) has launched a Call for Papers for its second special collection, which will focus on artificial intelligence and machine learning. Join host Alaina Webster as she welcomes CTS Associate Editors Dr. Mohamed Shahin and Dr. Qi Liu to discuss the types of submissions they’d most like to see as well [&#8230;]]]></description>
	<itunes:subtitle><![CDATA[Clinical and Translational Science (CTS) has launched a Call for Papers for its second special collection, which will focus on artificial intelligence and machine learning. Join host Alaina Webster as she welcomes CTS Associate Editors Dr. Mohamed Shahin]]></itunes:subtitle>
	<content:encoded><![CDATA[Clinical and Translational Science (CTS) has launched a Call for Papers for its second special collection, which will focus on artificial intelligence and machine learning. Join host Alaina Webster as she welcomes CTS Associate Editors Dr. Mohamed Shahin and Dr. Qi Liu to discuss the types of submissions they’d most like to see as well [&#8230;]]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/331/submit-your-artificial-intelligence-machine-learning-research-to-cts.mp3" length="7770094" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Clinical and Translational Science (CTS) has launched a Call for Papers for its second special collection, which will focus on artificial intelligence and machine learning. Join host Alaina Webster as she welcomes CTS Associate Editors Dr. Mohamed Shahin and Dr. Qi Liu to discuss the types of submissions they’d most like to see as well [&#8230;]]]></itunes:summary>
	<itunes:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></itunes:image>
	<image>
		<url>https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png</url>
		<title>Submit Your Artificial Intelligence/Machine Learning Research to CTS!</title>
	</image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>9:10</itunes:duration>
	<itunes:author><![CDATA[ASCPT Podcast Channel]]></itunes:author>	<googleplay:description><![CDATA[Clinical and Translational Science (CTS) has launched a Call for Papers for its second special collection, which will focus on artificial intelligence and machine learning. Join host Alaina Webster as she welcomes CTS Associate Editors Dr. Mohamed Shahin and Dr. Qi Liu to discuss the types of submissions they’d most like to see as well [&#8230;]]]></googleplay:description>
	<googleplay:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>The Story Behind the Science: CTS’s Mechanism of Action Mini Reviews</title>
	<link>https://ascptpod.com/podcast/the-story-behind-the-science-ctss-mechanism-of-action-mini-reviews/</link>
	<pubDate>Tue, 13 Feb 2024 18:09:38 +0000</pubDate>
	<dc:creator><![CDATA[ASCPT Podcast Channel]]></dc:creator>
	<guid isPermaLink="false">https://ascptpod.com/?post_type=podcast&#038;p=322</guid>
	<description><![CDATA[Dr. Mohamed Shahin, Associate Editor of Clinical and Translational Science, shares the thought process behind the newest CTS article type, the Mechanism of Action (MOA) Mini Review. Check out the latest published MOA papers or read up on formatting specifications and submission guidelines for this exciting article type. If you have questions about submitting this [&#8230;]]]></description>
	<itunes:subtitle><![CDATA[Dr. Mohamed Shahin, Associate Editor of Clinical and Translational Science, shares the thought process behind the newest CTS article type, the Mechanism of Action (MOA) Mini Review. Check out the latest published MOA papers or read up on formatting speci]]></itunes:subtitle>
	<content:encoded><![CDATA[Dr. Mohamed Shahin, Associate Editor of Clinical and Translational Science, shares the thought process behind the newest CTS article type, the Mechanism of Action (MOA) Mini Review. Check out the latest published MOA papers or read up on formatting specifications and submission guidelines for this exciting article type. If you have questions about submitting this [&#8230;]]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/322/the-story-behind-the-science-ctss-mechanism-of-action-mini-reviews.mp3" length="13263238" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Dr. Mohamed Shahin, Associate Editor of Clinical and Translational Science, shares the thought process behind the newest CTS article type, the Mechanism of Action (MOA) Mini Review. Check out the latest published MOA papers or read up on formatting specifications and submission guidelines for this exciting article type. If you have questions about submitting this [&#8230;]]]></itunes:summary>
	<itunes:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></itunes:image>
	<image>
		<url>https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png</url>
		<title>The Story Behind the Science: CTS’s Mechanism of Action Mini Reviews</title>
	</image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>16:05</itunes:duration>
	<itunes:author><![CDATA[ASCPT Podcast Channel]]></itunes:author>	<googleplay:description><![CDATA[Dr. Mohamed Shahin, Associate Editor of Clinical and Translational Science, shares the thought process behind the newest CTS article type, the Mechanism of Action (MOA) Mini Review. Check out the latest published MOA papers or read up on formatting specifications and submission guidelines for this exciting article type. If you have questions about submitting this [&#8230;]]]></googleplay:description>
	<googleplay:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Continuing the Conversation: Audience Questions from ASCPT Journal Family Webinar “Alternatives for Rifampin as a CYP3A Inducer in DDI Studies in View of N-Nitrosamine Impurity Issues”</title>
	<link>https://ascptpod.com/podcast/continuing-the-conversation/</link>
	<pubDate>Tue, 18 Jul 2023 11:00:31 +0000</pubDate>
	<dc:creator><![CDATA[ASCPT Podcast Channel]]></dc:creator>
	<guid isPermaLink="false">https://ascptpod.com/?post_type=podcast&#038;p=307</guid>
	<description><![CDATA[Moderators Drs. Murugesh Kandasamy and Mayur Ladumor are joined by webinar presenters Drs. Aernout van Haarst and Sabina Paglialunga as they continue answering questions from their ASCPT Journal Family webinar “Alternatives for Rifampin as a CYP3A Inducer in DDI Studies in View of N-Nitrosamine Impurity Issues.” The webinar is available open access on the ASCPT [&#8230;]]]></description>
	<itunes:subtitle><![CDATA[Moderators Drs. Murugesh Kandasamy and Mayur Ladumor are joined by webinar presenters Drs. Aernout van Haarst and Sabina Paglialunga as they continue answering questions from their ASCPT Journal Family webinar “Alternatives for Rifampin as a CYP3A Induce]]></itunes:subtitle>
	<content:encoded><![CDATA[Moderators Drs. Murugesh Kandasamy and Mayur Ladumor are joined by webinar presenters Drs. Aernout van Haarst and Sabina Paglialunga as they continue answering questions from their ASCPT Journal Family webinar “Alternatives for Rifampin as a CYP3A Inducer in DDI Studies in View of N-Nitrosamine Impurity Issues.” The webinar is available open access on the ASCPT [&#8230;]]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/307/continuing-the-conversation.mp3" length="15427797" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Moderators Drs. Murugesh Kandasamy and Mayur Ladumor are joined by webinar presenters Drs. Aernout van Haarst and Sabina Paglialunga as they continue answering questions from their ASCPT Journal Family webinar “Alternatives for Rifampin as a CYP3A Inducer in DDI Studies in View of N-Nitrosamine Impurity Issues.” The webinar is available open access on the ASCPT [&#8230;]]]></itunes:summary>
	<itunes:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></itunes:image>
	<image>
		<url>https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png</url>
		<title>Continuing the Conversation: Audience Questions from ASCPT Journal Family Webinar “Alternatives for Rifampin as a CYP3A Inducer in DDI Studies in View of N-Nitrosamine Impurity Issues”</title>
	</image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>25:33</itunes:duration>
	<itunes:author><![CDATA[ASCPT Podcast Channel]]></itunes:author>	<googleplay:description><![CDATA[Moderators Drs. Murugesh Kandasamy and Mayur Ladumor are joined by webinar presenters Drs. Aernout van Haarst and Sabina Paglialunga as they continue answering questions from their ASCPT Journal Family webinar “Alternatives for Rifampin as a CYP3A Inducer in DDI Studies in View of N-Nitrosamine Impurity Issues.” The webinar is available open access on the ASCPT [&#8230;]]]></googleplay:description>
	<googleplay:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Call for Papers: Artificial Intelligence and Machine Learning</title>
	<link>https://ascptpod.com/podcast/call-for-papers-artificial-intelligence-and-machine-learning/</link>
	<pubDate>Wed, 26 Apr 2023 13:00:47 +0000</pubDate>
	<dc:creator><![CDATA[ASCPT Podcast Channel]]></dc:creator>
	<guid isPermaLink="false">https://ascptpod.com/?post_type=podcast&#038;p=294</guid>
	<description><![CDATA[Clinical Pharmacology &#38; Therapeutics (CPT) has launched a Call for Papers for its January 2024 themed issue titled &#8220;The Application of Artificial Intelligence and Machine Learning (AI/ML) in Clinical Pharmacology and Therapeutics.&#8221; Join host Alaina Webster as she welcomes CPT’s Editor-in-Chief Dr. Piet van der Graaf, Associate Editor Dr. Amita Joshi, and Guest Editor Dr. [&#8230;]]]></description>
	<itunes:subtitle><![CDATA[Clinical Pharmacology &#38; Therapeutics (CPT) has launched a Call for Papers for its January 2024 themed issue titled &#8220;The Application of Artificial Intelligence and Machine Learning (AI/ML) in Clinical Pharmacology and Therapeutics.&#8221; Join h]]></itunes:subtitle>
	<content:encoded><![CDATA[Clinical Pharmacology &#38; Therapeutics (CPT) has launched a Call for Papers for its January 2024 themed issue titled &#8220;The Application of Artificial Intelligence and Machine Learning (AI/ML) in Clinical Pharmacology and Therapeutics.&#8221; Join host Alaina Webster as she welcomes CPT’s Editor-in-Chief Dr. Piet van der Graaf, Associate Editor Dr. Amita Joshi, and Guest Editor Dr. [&#8230;]]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/294/call-for-papers-artificial-intelligence-and-machine-learning.mp3" length="6747981" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Clinical Pharmacology &#38; Therapeutics (CPT) has launched a Call for Papers for its January 2024 themed issue titled &#8220;The Application of Artificial Intelligence and Machine Learning (AI/ML) in Clinical Pharmacology and Therapeutics.&#8221; Join host Alaina Webster as she welcomes CPT’s Editor-in-Chief Dr. Piet van der Graaf, Associate Editor Dr. Amita Joshi, and Guest Editor Dr. [&#8230;]]]></itunes:summary>
	<itunes:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></itunes:image>
	<image>
		<url>https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png</url>
		<title>Call for Papers: Artificial Intelligence and Machine Learning</title>
	</image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>9:59</itunes:duration>
	<itunes:author><![CDATA[ASCPT Podcast Channel]]></itunes:author>	<googleplay:description><![CDATA[Clinical Pharmacology &#38; Therapeutics (CPT) has launched a Call for Papers for its January 2024 themed issue titled &#8220;The Application of Artificial Intelligence and Machine Learning (AI/ML) in Clinical Pharmacology and Therapeutics.&#8221; Join host Alaina Webster as she welcomes CPT’s Editor-in-Chief Dr. Piet van der Graaf, Associate Editor Dr. Amita Joshi, and Guest Editor Dr. [&#8230;]]]></googleplay:description>
	<googleplay:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Call for Papers: Real-World Evidence and Real-World Data</title>
	<link>https://ascptpod.com/podcast/call-for-papers-real-world-evidence-and-real-world-data/</link>
	<pubDate>Wed, 19 Apr 2023 16:48:50 +0000</pubDate>
	<dc:creator><![CDATA[ASCPT Podcast Channel]]></dc:creator>
	<guid isPermaLink="false">https://ascptpod.com/?post_type=podcast&#038;p=292</guid>
	<description><![CDATA[Join Editor-in-Chief Dr. John Wagner and Associate Editor Dr. Paulien Ravenstijn as they discuss the FIRST EVER Call for Papers from Clinical and Translational Science (CTS). This special collection focusing on Real-World Evidence and Real-World Data, which will be a rolling collection, will initially publish in the second half of 2023, and the CTS editorial [&#8230;]]]></description>
	<itunes:subtitle><![CDATA[Join Editor-in-Chief Dr. John Wagner and Associate Editor Dr. Paulien Ravenstijn as they discuss the FIRST EVER Call for Papers from Clinical and Translational Science (CTS). This special collection focusing on Real-World Evidence and Real-World Data, wh]]></itunes:subtitle>
	<content:encoded><![CDATA[Join Editor-in-Chief Dr. John Wagner and Associate Editor Dr. Paulien Ravenstijn as they discuss the FIRST EVER Call for Papers from Clinical and Translational Science (CTS). This special collection focusing on Real-World Evidence and Real-World Data, which will be a rolling collection, will initially publish in the second half of 2023, and the CTS editorial [&#8230;]]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/292/call-for-papers-real-world-evidence-and-real-world-data.mp3" length="5891001" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Join Editor-in-Chief Dr. John Wagner and Associate Editor Dr. Paulien Ravenstijn as they discuss the FIRST EVER Call for Papers from Clinical and Translational Science (CTS). This special collection focusing on Real-World Evidence and Real-World Data, which will be a rolling collection, will initially publish in the second half of 2023, and the CTS editorial [&#8230;]]]></itunes:summary>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>8:14</itunes:duration>
	<itunes:author><![CDATA[ASCPT Podcast Channel]]></itunes:author>	<googleplay:description><![CDATA[Join Editor-in-Chief Dr. John Wagner and Associate Editor Dr. Paulien Ravenstijn as they discuss the FIRST EVER Call for Papers from Clinical and Translational Science (CTS). This special collection focusing on Real-World Evidence and Real-World Data, which will be a rolling collection, will initially publish in the second half of 2023, and the CTS editorial [&#8230;]]]></googleplay:description>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Translating Clinical Pharmacology for ALL</title>
	<link>https://ascptpod.com/podcast/translating-clinical-pharmacology-for-all/</link>
	<pubDate>Mon, 20 Mar 2023 21:25:27 +0000</pubDate>
	<dc:creator><![CDATA[ASCPT Podcast Channel]]></dc:creator>
	<guid isPermaLink="false">https://ascptpod.com/?post_type=podcast&#038;p=288</guid>
	<description><![CDATA[Clinical Pharmacology &#38; Therapeutics recently published its second themed issue of 2023 – Diversity, Equity, &#38; Inclusion: Translating Clinical Pharmacology for ALL. Join Editor-in-Chief Dr. Piet van der Graaf, Deputy Editor-in-Chief Dr. Kathy Giacomini, Associate Editor Dr. Karthik Venkatakrishnan, and Editor-in-Training Dr. Karen Brown as they discuss where diversity, equity, and inclusion (DEI) currently stands [&#8230;]]]></description>
	<itunes:subtitle><![CDATA[Clinical Pharmacology &#38; Therapeutics recently published its second themed issue of 2023 – Diversity, Equity, &#38; Inclusion: Translating Clinical Pharmacology for ALL. Join Editor-in-Chief Dr. Piet van der Graaf, Deputy Editor-in-Chief Dr. Kathy Gia]]></itunes:subtitle>
	<content:encoded><![CDATA[Clinical Pharmacology &#38; Therapeutics recently published its second themed issue of 2023 – Diversity, Equity, &#38; Inclusion: Translating Clinical Pharmacology for ALL. Join Editor-in-Chief Dr. Piet van der Graaf, Deputy Editor-in-Chief Dr. Kathy Giacomini, Associate Editor Dr. Karthik Venkatakrishnan, and Editor-in-Training Dr. Karen Brown as they discuss where diversity, equity, and inclusion (DEI) currently stands [&#8230;]]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/288/translating-clinical-pharmacology-for-all.mp3" length="10233003" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Clinical Pharmacology &#38; Therapeutics recently published its second themed issue of 2023 – Diversity, Equity, &#38; Inclusion: Translating Clinical Pharmacology for ALL. Join Editor-in-Chief Dr. Piet van der Graaf, Deputy Editor-in-Chief Dr. Kathy Giacomini, Associate Editor Dr. Karthik Venkatakrishnan, and Editor-in-Training Dr. Karen Brown as they discuss where diversity, equity, and inclusion (DEI) currently stands [&#8230;]]]></itunes:summary>
	<itunes:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></itunes:image>
	<image>
		<url>https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png</url>
		<title>Translating Clinical Pharmacology for ALL</title>
	</image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>11:34</itunes:duration>
	<itunes:author><![CDATA[ASCPT Podcast Channel]]></itunes:author>	<googleplay:description><![CDATA[Clinical Pharmacology &#38; Therapeutics recently published its second themed issue of 2023 – Diversity, Equity, &#38; Inclusion: Translating Clinical Pharmacology for ALL. Join Editor-in-Chief Dr. Piet van der Graaf, Deputy Editor-in-Chief Dr. Kathy Giacomini, Associate Editor Dr. Karthik Venkatakrishnan, and Editor-in-Training Dr. Karen Brown as they discuss where diversity, equity, and inclusion (DEI) currently stands [&#8230;]]]></googleplay:description>
	<googleplay:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Hesitation Does Not Equal Anti-Vaccination</title>
	<link>https://ascptpod.com/podcast/hesitation-does-not-equal-anti-vaccination/</link>
	<pubDate>Wed, 01 Feb 2023 14:00:00 +0000</pubDate>
	<dc:creator><![CDATA[ASCPT Podcast Channel]]></dc:creator>
	<guid isPermaLink="false">https://ascptpod.com/?post_type=podcast&#038;p=283</guid>
	<description><![CDATA[Expanding on a previous podcast discussing research published in Clinical and Translational Science, Drs. Pearl McElfish and Ramey Moore join moderator Dr. Erica Woodahl to delve into vaccine hesitancy and people classified as “hesitant adopters,” individuals who were wary of the COVID-19 vaccine but did, ultimately, receive at least one dose of the vaccine. Pearl, [&#8230;]]]></description>
	<itunes:subtitle><![CDATA[Expanding on a previous podcast discussing research published in Clinical and Translational Science, Drs. Pearl McElfish and Ramey Moore join moderator Dr. Erica Woodahl to delve into vaccine hesitancy and people classified as “hesitant adopters,” indivi]]></itunes:subtitle>
	<content:encoded><![CDATA[Expanding on a previous podcast discussing research published in Clinical and Translational Science, Drs. Pearl McElfish and Ramey Moore join moderator Dr. Erica Woodahl to delve into vaccine hesitancy and people classified as “hesitant adopters,” individuals who were wary of the COVID-19 vaccine but did, ultimately, receive at least one dose of the vaccine. Pearl, [&#8230;]]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/283/hesitation-does-not-equal-anti-vaccination.mp3" length="25660545" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Expanding on a previous podcast discussing research published in Clinical and Translational Science, Drs. Pearl McElfish and Ramey Moore join moderator Dr. Erica Woodahl to delve into vaccine hesitancy and people classified as “hesitant adopters,” individuals who were wary of the COVID-19 vaccine but did, ultimately, receive at least one dose of the vaccine. Pearl, [&#8230;]]]></itunes:summary>
	<itunes:image href="https://ascptpod.com/wp-content/uploads/2020/03/ascpt-podcast-network-cover-01.png"></itunes:image>
	<image>
		<url>https://ascptpod.com/wp-content/uploads/2020/03/ascpt-podcast-network-cover-01.png</url>
		<title>Hesitation Does Not Equal Anti-Vaccination</title>
	</image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>36:05</itunes:duration>
	<itunes:author><![CDATA[ASCPT Podcast Channel]]></itunes:author>	<googleplay:description><![CDATA[Expanding on a previous podcast discussing research published in Clinical and Translational Science, Drs. Pearl McElfish and Ramey Moore join moderator Dr. Erica Woodahl to delve into vaccine hesitancy and people classified as “hesitant adopters,” individuals who were wary of the COVID-19 vaccine but did, ultimately, receive at least one dose of the vaccine. Pearl, [&#8230;]]]></googleplay:description>
	<googleplay:image href="https://ascptpod.com/wp-content/uploads/2020/03/ascpt-podcast-network-cover-01.png"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>
	</channel>
</rss>
